Prevention, Intervention, and Care of Neurodegerative Diseases

A special issue of Healthcare (ISSN 2227-9032). This special issue belongs to the section "Chronic Care".

Deadline for manuscript submissions: closed (31 October 2022) | Viewed by 22299

Special Issue Editors


E-Mail Website
Guest Editor
Multiple Sclerosis Center, AHEPA, 2nd Neurological University Department, General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, Greece
Interests: neuroimmunology; neurodegenerative diseases; multiple sclerosis; neuroimaging; biomarkers; cognitive neuropsychology
Special Issues, Collections and Topics in MDPI journals

E-Mail Website
Guest Editor
Multiple Sclerosis Center, AHEPA, 2nd Neurological University Department, General Hospital of Thessaloniki, Aristotle University of Thessaloniki, Thessaloniki, Greece
Interests: neuroimmunology; neurodegenerative diseases; multiple sclerosis; neuroimaging; biomarkers; cognitive neuropsychology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

Our current ability to detect neurodegenerative diseases early and manage them is limited. The insidious processes underlying these conditions are only partly understood, while the treatments used have limited efficacies. Current research aims to understand the mechanisms underlying the progressive axonal loss in various neurologic conditions and seeks ways to properly monitor, quantify, and treat their relevant clinical implications. 

This Special Issue of Healthcare seeks commentaries, original research, short reports, and reviews focussing on challenges in detecting, monitoring, and treating neurodegenerative diseases. This Special Issue aims to provide information about advances in the research of various primarily neurodegenerative conditions such as dementia, Parkinson’s Disease, motor neurone disease, and diseases with evident neurodegenerative components such as multiple sclerosis.

Dr. Christos Bakirtzis
Prof. Dr. Marina Kleopatra Boziki
Prof. Dr. Nikolaos Grigoriadis
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Healthcare is an international peer-reviewed open access semimonthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • neurodegeneration
  • axonal loss

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • e-Book format: Special Issues with more than 10 articles can be published as dedicated e-books, ensuring wide and rapid dissemination.

Further information on MDPI's Special Issue polices can be found here.

Related Special Issue

Published Papers (8 papers)

Order results
Result details
Select all
Export citation of selected articles as:

Editorial

Jump to: Research, Review, Other

3 pages, 192 KiB  
Editorial
Prevention, Intervention and Care of Neurodegenerative Diseases
by Christos Bakirtzis, Marina-Kleopatra Boziki and Nikolaos Grigoriadis
Healthcare 2023, 11(16), 2349; https://doi.org/10.3390/healthcare11162349 - 21 Aug 2023
Viewed by 1932
Abstract
Chronic neurodegenerative diseases encompass a wide spectrum of disorders and affect millions of people worldwide [...] Full article
(This article belongs to the Special Issue Prevention, Intervention, and Care of Neurodegerative Diseases)

Research

Jump to: Editorial, Review, Other

11 pages, 283 KiB  
Article
Risk Prediction Performance of the Thai Cardiovascular Risk Score for Mild Cognitive Impairment in Adults with Metabolic Risk Factors in Thailand
by Nida Buawangpong, Chanchanok Aramrat, Kanokporn Pinyopornpanish, Arintaya Phrommintikul, Atiwat Soontornpun, Wichuda Jiraporncharoen, Suphawita Pliannuom and Chaisiri Angkurawaranon
Healthcare 2022, 10(10), 1959; https://doi.org/10.3390/healthcare10101959 - 7 Oct 2022
Cited by 4 | Viewed by 2124
Abstract
Individuals with metabolic risks are at high risk of cognitive impairment. We aimed to investigate whether the Thai Cardiovascular Risk (TCVR) score can be used to predict mild cognitive impairment (MCI) in Thai adults with metabolic risks. The study was conducted using secondary [...] Read more.
Individuals with metabolic risks are at high risk of cognitive impairment. We aimed to investigate whether the Thai Cardiovascular Risk (TCVR) score can be used to predict mild cognitive impairment (MCI) in Thai adults with metabolic risks. The study was conducted using secondary data of patients with metabolic risks from Maharaj Nakorn Chiang Mai Hospital. MCI was indicated by an MoCA score of less than 25. Six different TCVR models were used with various combinations of ten different variables for predicting the risk of MCI. The area under the receiver operator characteristic curve (AuROC) and Hosmer–Lemeshow goodness of fit tests were used for determining discriminative performance and model calibration. The sensitivity of the discriminative performance was further evaluated by stratifying by age and gender. From a total of 421 participants, 348 participants had MCI. All six TCVR models showed a similar AuROC, varying between 0.58 and 0.61. The anthropometric-based model showed the best risk prediction performance in the older age group (AuROC 0.69). The laboratory-based model provided the highest discriminative performance for the younger age group (AuROC 0.60). There is potential for the development of an MCI risk model based on values from routine cardiovascular risk assessments among patients with metabolic risks. Full article
(This article belongs to the Special Issue Prevention, Intervention, and Care of Neurodegerative Diseases)
12 pages, 437 KiB  
Article
Effects of Multimodal Rehabilitation on the Activities of Daily Living, Quality of Life, and Burden of Care for Patients with Parkinson’s Disease: A Randomized Control Study
by Hyun-Se Choi and Seung-Hyun Cho
Healthcare 2022, 10(10), 1888; https://doi.org/10.3390/healthcare10101888 - 27 Sep 2022
Cited by 6 | Viewed by 2767
Abstract
Background: Parkinson’s disease reduces patients’ function, activities of daily living, and quality of life, and increases their guardians’ burden of care. This study verified the effectiveness of a multimodal rehabilitation programme for patients with Parkinson’s disease. Trial design: This study was a multicentre [...] Read more.
Background: Parkinson’s disease reduces patients’ function, activities of daily living, and quality of life, and increases their guardians’ burden of care. This study verified the effectiveness of a multimodal rehabilitation programme for patients with Parkinson’s disease. Trial design: This study was a multicentre parallel randomised controlled, single-blind, trial conducted in three hospitals in Korea. Methods: A central randomisation centre used computer generated tables to randomly allocate 60 of 75 patients with Parkinson’s disease who fulfilled the study requirements into experimental (n = 30; multimodal rehabilitation; consisting of daily living training, guardian education, home environment modification, fine muscle exercise, balance training, and training using auxiliary tools performed 50 min per session, twice a week, in 10 sessions) and control (n = 30; traditional rehabilitation; consisting of task-oriented training, joint exercise, and daily living training performed 50 min per session, twice a week, in 10 sessions) groups. Results: Multimodal rehabilitation for Parkinson’s disease significantly improved the activities of daily living (p < 0.01) and quality of life of patients (p < 0.001) and eased the guardians’ burden of care (p < 0.001). Conclusions: Multimodal rehabilitation is suggested to improve activities of daily living, quality of life of patients with Parkinson’s disease, and reduce the burden of care of their guardians. Full article
(This article belongs to the Special Issue Prevention, Intervention, and Care of Neurodegerative Diseases)
Show Figures

Figure 1

16 pages, 613 KiB  
Article
Using the Concept of Health Literacy to Understand How People Living with Motor Neurone Disease and Carers Engage in Healthcare: A Longitudinal Qualitative Study
by Camille Paynter, Susan Mathers, Heidi Gregory, Adam P. Vogel and Madeline Cruice
Healthcare 2022, 10(8), 1371; https://doi.org/10.3390/healthcare10081371 - 24 Jul 2022
Cited by 4 | Viewed by 2251
Abstract
The growing body of information-seeking and decision-making literature in motor neurone disease (MND) has not yet explored the impact of health literacy. Health literacy relates to the skills people have to access, understand, and use health information and is influenced by motivation to [...] Read more.
The growing body of information-seeking and decision-making literature in motor neurone disease (MND) has not yet explored the impact of health literacy. Health literacy relates to the skills people have to access, understand, and use health information and is influenced by motivation to engage with healthcare. We aimed to better understand how people affected by MND engage in healthcare by examining longitudinal interview data using the construct of health literacy. Semi-structured interviews were conducted with 19 persons living with MND and 15 carers recruited from a specialist MND clinic using maximum variation sampling. Transcripts were deductively coded using a framework of health literacy behaviours. The analysis used a matrix-based approach for thematic analysis of longitudinal data. People living with MND and carers sought nuanced information dependent on their priorities and attitudes. Information uptake was influenced by perceived relevancy and changed over time. Time allowed opportunity to reflect on and understand the significance of information provided. The findings indicate that persons living with MND and carers benefit when information and consultations are adapted to meet their communication needs. The results highlight the potential benefits of gaining an early understanding of and accommodating the communication needs, personal preferences, and emotional readiness for information for persons living with MND and their carers. Full article
(This article belongs to the Special Issue Prevention, Intervention, and Care of Neurodegerative Diseases)
Show Figures

Figure 1

Review

Jump to: Editorial, Research, Other

22 pages, 2946 KiB  
Review
Deep Learning Techniques for the Effective Prediction of Alzheimer’s Disease: A Comprehensive Review
by K Aditya Shastry, V Vijayakumar, Manoj Kumar M V, Manjunatha B A and Chandrashekhar B N
Healthcare 2022, 10(10), 1842; https://doi.org/10.3390/healthcare10101842 - 23 Sep 2022
Cited by 11 | Viewed by 3074
Abstract
“Alzheimer’s disease” (AD) is a neurodegenerative disorder in which the memory shrinks and neurons die. “Dementia” is described as a gradual decline in mental, psychological, and interpersonal qualities that hinders a person’s ability to function autonomously. AD is the most common degenerative brain [...] Read more.
“Alzheimer’s disease” (AD) is a neurodegenerative disorder in which the memory shrinks and neurons die. “Dementia” is described as a gradual decline in mental, psychological, and interpersonal qualities that hinders a person’s ability to function autonomously. AD is the most common degenerative brain disease. Among the first signs of AD are missing recent incidents or conversations. “Deep learning” (DL) is a type of “machine learning” (ML) that allows computers to learn by doing, much like people do. DL techniques can attain cutting-edge precision, beating individuals in certain cases. A large quantity of tagged information with multi-layered “neural network” architectures is used to perform analysis. Because significant advancements in computed tomography have resulted in sizable heterogeneous brain signals, the use of DL for the timely identification as well as automatic classification of AD has piqued attention lately. With these considerations in mind, this paper provides an in-depth examination of the various DL approaches and their implementations for the identification and diagnosis of AD. Diverse research challenges are also explored, as well as current methods in the field. Full article
(This article belongs to the Special Issue Prevention, Intervention, and Care of Neurodegerative Diseases)
Show Figures

Figure 1

9 pages, 266 KiB  
Review
Optical Coherence Tomography and Optical Coherence Tomography with Angiography in Multiple Sclerosis
by Ioannis-Nikolaos Chalkias, Christos Bakirtzis, Demetrios Pirounides, Marina Kleopatra Boziki and Nikolaos Grigoriadis
Healthcare 2022, 10(8), 1386; https://doi.org/10.3390/healthcare10081386 - 25 Jul 2022
Cited by 13 | Viewed by 2366
Abstract
Multiple sclerosis (MS) is an inflammatory and neurodegenerative, potentially disabling disease of the central nervous system. OCT (Optical Coherence Tomography) and OCT-A (Optical Coherence Tomography with Angiography) are imaging techniques for the retina and choroid that are used in the diagnosis and monitoring [...] Read more.
Multiple sclerosis (MS) is an inflammatory and neurodegenerative, potentially disabling disease of the central nervous system. OCT (Optical Coherence Tomography) and OCT-A (Optical Coherence Tomography with Angiography) are imaging techniques for the retina and choroid that are used in the diagnosis and monitoring of ophthalmological conditions. Their use has recently expanded the study of several autoimmune disorders, including MS. Although their application in MS remains unclear, the results seem promising. This review aimed to provide insight into the most recent OCT and OCT-A findings in MS and may function as a reference point for future research. According to the current literature, the retinal nerve fibre layer (RNFL) and ganglion cell-inner plexiform complex (GC-IPL) are significantly reduced in people with MS and are inversely correlated with disease duration. The use of OCT might help distinguish between MS and neuromyelitis optica spectrum disorders (NMOSD), as the latter presents with more pronounced thinning in both the RNFL and GC-IPL. The OCT-A findings in MS include reduced vessel density in the macula, peripapillary area, or both, and the enlargement of the foveal avascular zone (FAZ) in the setting of optic neuritis. Additionally, OCT-A might be able to detect damage in the very early stages of the disease as well as disease progression in severe cases. Full article
(This article belongs to the Special Issue Prevention, Intervention, and Care of Neurodegerative Diseases)

Other

10 pages, 1028 KiB  
Brief Report
What Do We Know So Far about Ofatumumab for Relapsing Multiple Sclerosis? A Meta-Analytical Study
by Hafiza Munazza Taj, Maryam Talib, Sania Siddiqa, Azza Sarfraz, Zouina Sarfraz, Karla Robles-Velasco and Ivan Cherrez-Ojeda
Healthcare 2022, 10(11), 2199; https://doi.org/10.3390/healthcare10112199 - 2 Nov 2022
Cited by 1 | Viewed by 2456
Abstract
Ofatumumab is a monoclonal antibody that reduces the level of B cells that alter the progression of relapsing multiple sclerosis. Originally approved by the Food and Drug Administration (FDA) in August 2020, this meta-analysis determines the outcomes of four randomized controlled trials (RCTs) [...] Read more.
Ofatumumab is a monoclonal antibody that reduces the level of B cells that alter the progression of relapsing multiple sclerosis. Originally approved by the Food and Drug Administration (FDA) in August 2020, this meta-analysis determines the outcomes of four randomized controlled trials (RCTs) for endline outcomes of Gadolinium-enhancing T1 lesions on MRI scans reported as Cohen’s d and relapse rate reported as risk ratio. All four RCTs reported favorable findings of gadolinium-enhancing T1 lesions (Cohen’s d = −0.44, p < 0.00001). The relapse rate was reduced by 46% post ofatumumab administration (RR = 0.54, p < 0.00001). With 14 ongoing trials in this area, more data is required to consolidate our findings. Full article
(This article belongs to the Special Issue Prevention, Intervention, and Care of Neurodegerative Diseases)
Show Figures

Figure 1

18 pages, 1224 KiB  
Systematic Review
Interventions within the Scope of Occupational Therapy in the Hospital Discharge Process Post-Stroke: A Systematic Review
by Patricia García-Pérez, José Pablo Lara, María del Carmen Rodríguez-Martínez and Carlos de la Cruz-Cosme
Healthcare 2022, 10(9), 1645; https://doi.org/10.3390/healthcare10091645 - 29 Aug 2022
Cited by 3 | Viewed by 4635
Abstract
Stroke is one of the main causes of disability in adulthood. Its rehabilitation is a complex process that requires a multidisciplinary team of specialised professionals. The main goal of this review was to determine the impact of occupational therapy intervention post-stroke on the [...] Read more.
Stroke is one of the main causes of disability in adulthood. Its rehabilitation is a complex process that requires a multidisciplinary team of specialised professionals. The main goal of this review was to determine the impact of occupational therapy intervention post-stroke on the home discharge process. A systematic search was carried out of the following databases: Pubmed, Web of Science, PsycINFO, Scopus, Otseeker, and Dialnet. A screening was performed taking into account the type of article, including exclusively RCT, and type of intervention, only including interventions within the scope of occupational therapy that take place during the process of hospital discharge post-stroke. A total of 2285 citations were identified in the search from which 13 articles met the inclusion criteria. Comparisons of the groups indicated that early occupational therapy intervention during the process of hospital discharge can be effective in terms of functional recovery and can lead to the caregiver seeing improvements in self-efficacy and fatigue. In addition, the inclusion of a caregiver in the intervention influences the patient’s adherence to treatment, leading to a reduction in the cost of treatment and rehabilitation. Full article
(This article belongs to the Special Issue Prevention, Intervention, and Care of Neurodegerative Diseases)
Show Figures

Figure 1

Back to TopTop